Renaissance Technologies’s Champions Oncology CSBR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.33M Buy
181,039
+29,000
+19% +$214K ﹤0.01% 2346
2025
Q1
$1.32M Buy
152,039
+13,200
+10% +$115K ﹤0.01% 2234
2024
Q4
$1.19M Buy
138,839
+18,848
+16% +$162K ﹤0.01% 2393
2024
Q3
$584K Sell
119,991
-2,600
-2% -$12.7K ﹤0.01% 2713
2024
Q2
$634K Sell
122,591
-2,100
-2% -$10.9K ﹤0.01% 2585
2024
Q1
$611K Sell
124,691
-100
-0.1% -$490 ﹤0.01% 2782
2023
Q4
$701K Sell
124,791
-1,000
-0.8% -$5.62K ﹤0.01% 2599
2023
Q3
$781K Buy
125,791
+900
+0.7% +$5.59K ﹤0.01% 2464
2023
Q2
$797K Sell
124,891
-1,600
-1% -$10.2K ﹤0.01% 2604
2023
Q1
$508K Sell
126,491
-7,400
-6% -$29.7K ﹤0.01% 2878
2022
Q4
$604K Sell
133,891
-9,058
-6% -$40.9K ﹤0.01% 2842
2022
Q3
$1.07M Sell
142,949
-21,397
-13% -$160K ﹤0.01% 2453
2022
Q2
$1.32M Sell
164,346
-5,593
-3% -$44.8K ﹤0.01% 2521
2022
Q1
$1.38M Sell
169,939
-20,807
-11% -$169K ﹤0.01% 2504
2021
Q4
$1.6M Sell
190,746
-30,400
-14% -$254K ﹤0.01% 2325
2021
Q3
$2.26M Sell
221,146
-6,900
-3% -$70.5K ﹤0.01% 1996
2021
Q2
$2.34M Sell
228,046
-387
-0.2% -$3.98K ﹤0.01% 2153
2021
Q1
$2.58M Buy
228,433
+6,687
+3% +$75.6K ﹤0.01% 2053
2020
Q4
$2.39M Sell
221,746
-18,280
-8% -$197K ﹤0.01% 2014
2020
Q3
$2.22M Buy
240,026
+27,080
+13% +$250K ﹤0.01% 2069
2020
Q2
$2.04M Buy
212,946
+35,900
+20% +$343K ﹤0.01% 2175
2020
Q1
$1.31M Sell
177,046
-10,300
-5% -$76.2K ﹤0.01% 2285
2019
Q4
$1.56M Buy
187,346
+2,300
+1% +$19.2K ﹤0.01% 2428
2019
Q3
$1.05M Buy
185,046
+4,400
+2% +$24.9K ﹤0.01% 2576
2019
Q2
$1.41M Sell
180,646
-11,300
-6% -$88.5K ﹤0.01% 2530
2019
Q1
$1.88M Sell
191,946
-47,600
-20% -$466K ﹤0.01% 2338
2018
Q4
$1.87M Sell
239,546
-26,300
-10% -$205K ﹤0.01% 2270
2018
Q3
$4.64M Buy
265,846
+165,246
+164% +$2.89M ﹤0.01% 1853
2018
Q2
$638K Buy
100,600
+39,000
+63% +$247K ﹤0.01% 2761
2018
Q1
$224K Sell
61,600
-495
-0.8% -$1.8K ﹤0.01% 3155
2017
Q4
$241K Buy
62,095
+14,095
+29% +$54.7K ﹤0.01% 3085
2017
Q3
$176K Buy
48,000
+34,000
+243% +$125K ﹤0.01% 3025
2017
Q2
$36K Buy
+14,000
New +$36K ﹤0.01% 3138